Yan Named Associate Dean of Research and Innovation at Pharmacy College
CINCINNATIBingfang Yan, PhD, has been named associate dean of research and innovation at the University of Cincinnati James L. Winkle College of Pharmacy. In this newly created position, Yan will direct the graduate program, provide leadership on new initiatives, help to increase research productivity and mentor junior faculty in their research.
He also holds the title of professor in the division of pharmaceutical sciences.
"It is critical for us to have a senior leader and mentor at the college to help us to continue to improve our research granting success, which has more than doubled since 2014, says Dean Neil MacKinnon, PhD, noting that college of pharmacy rankings are strongly correlated to research funding. "We are excited to have Dr. Yan on board at the college.
Yan joins the Winkle College of Pharmacy from the University of Rhode Island. His foundation is in veterinary medicine, but he has advanced training in microbiology and immunology, pharmacology/toxicology and tumor biology.
Yans laboratory, which has repeatedly been funded by the NIH, was among the first to clone and characterize the gene encoding the pregnane X receptor (PXR), and the gene encoding differentiated embryo-chondrocyte-expresse gene 1 (DEC1).
PXR is a master regulator for drug-metabolizing enzymes and transporters, whereas DEC1 is a circadian regulator with oncogenic involvement.
Yan frequently serves on scientific review panels at both the NIH and the Environmental Protection Agency (EPA) and is currently a standing member of NIH Study Section INMP.
For additional information about the college, visit the website.
Tags
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.